Pomalyst Drug Interactions
Currently displaying 88 drugs known to have a major interaction with Pomalyst (pomalidomide).
- 88 major drug interactions
- 288 moderate drug interactions
Major interactions with Pomalyst (pomalidomide)
Note: Showing generic names only.
A
- abrocitinib
- adalimumab
- alemtuzumab
- allogeneic processed thymus tissue
- atezolizumab
- avatrombopag
- avelumab
B
C
- C1 esterase inhibitor (human)
- cemiplimab
- certolizumab
- chikungunya vaccine, live (cvx 317)
- chloramphenicol
- chlorotrianisene
- cholera vaccine, live
- cladribine
- clozapine
- conestat alfa
- conjugated estrogens
- conjugated estrogens topical
D
- darbepoetin alfa
- deferiprone
- dehydroepiandrosterone
- dengue vaccine
- deucravacitinib
- dienestrol topical
- diethylstilbestrol
- dostarlimab
- drospirenone
- durvalumab
E
- eltrombopag
- epoetin alfa
- epoetin beta-methoxy polyethylene glycol
- esterified estrogens
- estradiol
- estradiol topical
- estrone
- estropipate
- estropipate topical
- etanercept
- ethinyl estradiol
- etrasimod
F
G
I
L
M
N
O
P
Q
R
- radium 223 dichloride
- raloxifene
- retifanlimab
- ritlecitinib
- romiplostim
- rotavirus vaccine
- rubella virus vaccine
S
T
- talimogene laherparepvec
- tamoxifen
- teriflunomide
- tofacitinib
- toremifene
- toripalimab
- typhoid vaccine, live
U
V
Y
Z
Pomalyst alcohol/food interactions
There is 1 alcohol/food interaction with Pomalyst (pomalidomide).
Pomalyst disease interactions
There are 7 disease interactions with Pomalyst (pomalidomide) which include:
- thromboembolism
- hematologic toxicities
- hepatic impairment
- neuropathy
- renal impairment
- smoking
- tumor lysis syndrome
More about Pomalyst (pomalidomide)
- Pomalyst consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (3)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.